Public funding highlights: 3Q18

Public funding highlights: 3Q18

Selected developments and initiatives in 3Q18 from major sources of public funding including NIH, the U.K.’s Medical Research Council (MRC), the Innovative Medicines Initiative (IMI), the Canadian Institutes of Health Research (CIHR) and Singapore’s Agency for Science Technology and Research (A*STAR).

DateAgencySummaryType
July 3A*STARA*STAR’s Institute of Molecular and Cell Biology partnered with Indivumed GmbH to characterize the company's cancer biobank, adding proteomic and phosphoproteomic data to the databaseDeals
July 16NIHFindings by researchers at NIH's National Institute of General Medical Sciences (NIGMS)

Read the full 812 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE